Pure Global AI
ANVISA registration 80134860308Active

ANTI-DARATUMUMAB ANTIBODY

ANVISA Registration Number: 80134860308GRIFOLS BRASIL LTDAMEDION GRIFOLS DIAGNOSTICS AGRisk Class II
Verified
Device names
Technical name
ANTI-DARATUMUMAB ANTIBODY
View exact technical-name matches →
PT: ANTICORPO ANTI-DARATUMUMAB
Commercial name
Grifols sCD38
View exact commercial-name matches →
Risk class
Class II
Registration details
Registration Number
80134860308
Process Number
25351458325202412
CNPJ
02513899000171
Company information
Registration Holder
GRIFOLS BRASIL LTDA
Manufacturer
MEDION GRIFOLS DIAGNOSTICS AG
Manufacturing Country
Switzerland
PT: SUÍÇA
Dates and status
Publication Date
Feb 17, 2025
Validity
VIGENTE
Last Updated
08/18/2026 19:00:00
About this record

Access comprehensive regulatory information for ANTI-DARATUMUMAB ANTIBODY in Brazil's medical device market through Pure Global AI's free database. This Risk Class II medical device is registered under ANVISA number 80134860308 and manufactured by MEDION GRIFOLS DIAGNOSTICS AG. The registration is held by GRIFOLS BRASIL LTDA with validity until currently active (VIGENTE).

This page shows the facts attached to this official registry row. Exact-name links return deterministic registry matches; open-ended comparison and market analysis are handed to AI Search with this record's context, without asserting that similar names represent the same entity.